Recap: Impel Pharmaceuticals Q1 Earnings

Impel Pharmaceuticals IMPL reported its Q1 earnings results on Friday, May 12, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Impel Pharmaceuticals missed estimated earnings by 41.11%, reporting an EPS of $-1.27 versus an estimate of $-0.9.

Revenue was up $2.61 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.14 which was followed by a 3.82% increase in the share price the next day.

Here's a look at Impel Pharmaceuticals's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -1.11 -1 -1.05 -1.05
EPS Actual -0.97 -1.31 -1.09 -1.17
Revenue Estimate 4.97M 5.82M 3.83M 1.80M
Revenue Actual 5.01M 3.08M 2.80M 1.76M

To track all earnings releases for Impel Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!